Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v8-FR
Language French French
Date Updated 2024-01-18 2023-12-12
Drug Identification Number 00886858 00886858
Brand name EMLA CREAM EMLA CREAM
Common or Proper name lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings lidocaine 2.5% and prilocaine 2.5% 5g Tube with 2 Tegaderm dressings
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients LIDOCAINE PRILOCAINE LIDOCAINE PRILOCAINE
Strength(s) 2.5% 2.5% 2.5% 2.5%
Dosage form(s) CREAM CREAM
Route of administration TOPICAL TOPICAL TOPICAL TOPICAL
Packaging size 1 Tube 1 Tube
ATC code D04AB D04AB
ATC description ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC. ANTIPRURITICS,INCL ANTIHIST,ANESTHET,ETC.
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2023-12-15 2023-12-15
Actual start date 2023-12-20
Estimated end date 2024-01-15 2024-01-01
Actual end date 2024-01-08
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments VR44798CA1 / CAD2EM012B1 EMLA 25MG:25MG/G CRE TB 1X5G CA ASP VR44798CA1 / CAD2EM012B1 EMLA 25MG:25MG/G CRE TB 1X5G CA ASP
Health Canada comments